<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Apolipoprotein A-I gene transfer exerts immunomodulatory effects and reduces vascular inflammation and fibrosis in ob/ob mice</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Frank</forename><surname>Spillmann</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">Charité-University-Medicine Berlin</orgName>
								<orgName type="institution" key="instit2">Campus Virchow Klinikum (CVK)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">Charité-University-Medicine Berlin</orgName>
								<orgName type="institution" key="instit2">Campus Virchow Klinikum (CVK)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bart</forename><surname>De Geest</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Center for Molecular and Vascular Biology</orgName>
								<orgName type="department" key="dep2">Department of Cardiovascular Sciences</orgName>
								<orgName type="institution">Catholic University of Leuven</orgName>
								<address>
									<settlement>Leuven</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ilayaraja</forename><surname>Muthuramu</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Center for Molecular and Vascular Biology</orgName>
								<orgName type="department" key="dep2">Department of Cardiovascular Sciences</orgName>
								<orgName type="institution">Catholic University of Leuven</orgName>
								<address>
									<settlement>Leuven</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ruhul</forename><surname>Amin</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Center for Molecular and Vascular Biology</orgName>
								<orgName type="department" key="dep2">Department of Cardiovascular Sciences</orgName>
								<orgName type="institution">Catholic University of Leuven</orgName>
								<address>
									<settlement>Leuven</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kapka</forename><surname>Miteva</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapy (BCRT)</orgName>
								<orgName type="institution">Charité-University-Medicine Berlin</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum (CVK), Südstrasse 2</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapy (BCRT)</orgName>
								<orgName type="institution" key="instit1">Charité-University-Medicine Berlin</orgName>
								<orgName type="institution" key="instit2">Campus Virchow Klinikum (CVK)</orgName>
								<address>
									<addrLine>Südstrasse 2</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Burkert</forename><surname>Pieske</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">Charité-University-Medicine Berlin</orgName>
								<orgName type="institution" key="instit2">Campus Virchow Klinikum (CVK)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">Charité-University-Medicine Berlin</orgName>
								<orgName type="institution" key="instit2">Campus Virchow Klinikum (CVK)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Deutsches Zentrum für Herz Kreislaufforschung (DZHK)</orgName>
								<address>
									<addrLine>Standort Berlin/Charité</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">Department of Cardiology</orgName>
								<orgName type="department" key="dep2">Deutsches Herzzentrum Berlin (DHZB)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carsten</forename><surname>Tschöpe</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">Charité-University-Medicine Berlin</orgName>
								<orgName type="institution" key="instit2">Campus Virchow Klinikum (CVK)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapy (BCRT)</orgName>
								<orgName type="institution">Charité-University-Medicine Berlin</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum (CVK), Südstrasse 2</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">Charité-University-Medicine Berlin</orgName>
								<orgName type="institution" key="instit2">Campus Virchow Klinikum (CVK)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapy (BCRT)</orgName>
								<orgName type="institution" key="instit1">Charité-University-Medicine Berlin</orgName>
								<orgName type="institution" key="instit2">Campus Virchow Klinikum (CVK)</orgName>
								<address>
									<addrLine>Südstrasse 2</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Deutsches Zentrum für Herz Kreislaufforschung (DZHK)</orgName>
								<address>
									<addrLine>Standort Berlin/Charité</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Sophie</forename><forename type="middle">Van</forename><surname>Linthout</surname></persName>
							<email>sophie.van-linthout@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">Charité-University-Medicine Berlin</orgName>
								<orgName type="institution" key="instit2">Campus Virchow Klinikum (CVK)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapy (BCRT)</orgName>
								<orgName type="institution">Charité-University-Medicine Berlin</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum (CVK), Südstrasse 2</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">Charité-University-Medicine Berlin</orgName>
								<orgName type="institution" key="instit2">Campus Virchow Klinikum (CVK)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapy (BCRT)</orgName>
								<orgName type="institution" key="instit1">Charité-University-Medicine Berlin</orgName>
								<orgName type="institution" key="instit2">Campus Virchow Klinikum (CVK)</orgName>
								<address>
									<addrLine>Südstrasse 2</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Deutsches Zentrum für Herz Kreislaufforschung (DZHK)</orgName>
								<address>
									<addrLine>Standort Berlin/Charité</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Apolipoprotein A-I gene transfer exerts immunomodulatory effects and reduces vascular inflammation and fibrosis in ob/ob mice</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">38DBB17D1BCD9EEA33D91E2142042706</idno>
					<idno type="DOI">10.1186/s12950-016-0131-6</idno>
					<note type="submission">Received: 23 March 2016 Accepted: 19 July 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:34+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>HDL</term>
					<term>Immunomodulation</term>
					<term>Aorta</term>
					<term>Vascular fibrosis</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Obesity is associated with vascular inflammation, fibrosis and reduced high-density lipoproteins (HDL)-cholesterol.</s><s>We aimed to investigate whether adenoviral gene transfer with human apolipoprotein (apo) A-I (Ad.A-I), the main apo of HDL, could exert immunomodulatory effects and counteract vascular inflammation and fibrosis in ob/ob mice.</s><s>Methods: Ad.A-I transfer was performed in 8 weeks (w) old ob/ob mice, which were sacrificed 7 w later.</s><s>The aorta was excised for mRNA analysis and the spleen for splenocyte isolation for subsequent flow cytometry and co-culture with murine fibroblasts.</s><s>HDL was added to mononuclear cells (MNC) and fibroblasts to assess their impact on adhesion capacity and collagen deposition, respectively.</s></p><p><s>Results: Ad.A-I led to a 1.8-fold (p &lt; 0.05) increase in HDL-cholesterol versus control ob/ob mice at the day of sacrifice, which was paralleled by a decrease in aortic TNF-α and VCAM-1 mRNA expression.</s><s>Pre-culture of MNC with HDL decreased their adhesion to TNF-α-activated HAEC.</s><s>Ad.A-I exerted immunomodulatory effects as evidenced by a downregulation of aortic NOD2 and NLRP3 mRNA expression and by a 12 %, 6.9 %, and 15 % decrease of the induced proliferation/activity of total splenic MNC, CD4+, and CD8+ cells in ob/ob Ad.A-I versus control ob/ob mice, respectively (p &lt; 0.05).</s><s>Ad.A-I further reduced aortic collagen I and III mRNA expression by 62 % and 66 %, respectively (p &lt; 0.0005), and abrogated the potential of ob/ob splenocytes to induce the collagen content in murine fibroblasts upon co-culture.</s><s>Finally, HDL decreased the TGF-ß1-induced collagen deposition of murine fibroblasts in vitro.</s></p><p><s>Conclusions: Apo A-I transfer counteracts vascular inflammation and fibrosis in ob/ob mice.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>Obesity is an inflammatory disorder <ref type="bibr" target="#b0">[1]</ref> associated with endothelial dysfunction <ref type="bibr" target="#b1">[2]</ref>, vascular fibrosis <ref type="bibr" target="#b2">[3]</ref>, and an increased cardiovascular risk <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b4">5]</ref>.</s><s>It is characterized by a chronic low-grade activation of the innate immune system <ref type="bibr" target="#b0">[1]</ref>.</s><s>This involves among others the NOD-like receptor (NLR) family of pattern recognition receptors, including the NLRP3 inflammasome <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b6">7]</ref>, which senses obesity-induced stress signals like cholesterol crystals <ref type="bibr" target="#b5">[6]</ref>, and NOD2 <ref type="bibr" target="#b7">[8]</ref>.</s><s>Both NLRP3 and NOD2 are expressed on endothelial cells, stimulate endothelial inflammation <ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref>, and are involved in the pathogenesis of fibrosis <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12]</ref>.</s><s>Inflammation is a wellestablished trigger of fibrosis <ref type="bibr" target="#b12">[13]</ref>: it can "classically" induce the activation/proliferation and transdifferentiation of resident fibroblasts to myofibroblasts and induce endothelial-to-mesenchymal-transition (EndMT) <ref type="bibr" target="#b13">[14]</ref>, a process by which endothelial cells transdifferentiate into mesenchymal-like cells, characterized by induced αsmooth muscle actin expression, loss of endothelial cell markers, and increased collagen deposition <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref>.</s></p><p><s>Obesity is associated with low high-density lipoprotein (HDL) cholesterol levels, by which the body weight inversely correlates with HDL cholesterol <ref type="bibr" target="#b17">[18]</ref>.</s><s>HDL cholesterol levels are also decreased in several other inflammatory disorders including atherosclerosis <ref type="bibr" target="#b18">[19]</ref>, systemic lupus erythematosus <ref type="bibr" target="#b19">[20]</ref>, and rheumatoid arthritis <ref type="bibr" target="#b20">[21]</ref>, suggesting a link between HDL and the immune response.</s><s>Apolipoprotein A-I (apo A-I) is the principal apolipoprotein of HDL and plasma levels of this apolipoprotein strongly correlate with HDL cholesterol levels.</s><s>At the molecular and cellular level, HDL/ apo A-I are known to reduce Toll like receptor 4 expression <ref type="bibr" target="#b21">[22]</ref>, inhibit antigen presentation <ref type="bibr" target="#b22">[23]</ref>, and reduce T cell proliferation <ref type="bibr" target="#b23">[24]</ref>.</s><s>Besides these immunomodulatory characteristics, HDL/apo A-I are particularly known for their endothelial-protective properties including their capacity to facilitate vascular relaxation via activation of eNOS <ref type="bibr" target="#b24">[25]</ref>, to restore impaired NO bioavailability <ref type="bibr" target="#b25">[26]</ref>, and to decrease the expression of vascular adhesion molecules <ref type="bibr" target="#b26">[27]</ref>.</s><s>Besides these well-established endothelialprotective effects, there is accumulating evidence that HDL and apo A-I also have anti-fibrotic properties: overexpression of apo A-I in the lung abrogates fibrosis in experimental silicosis <ref type="bibr" target="#b27">[28]</ref>, low apo A-I levels predict liver fibrosis in hepatitis C patients <ref type="bibr" target="#b28">[29]</ref>, and HDL inversely correlate to the serum marker of cardiac fibrosis, procollagen type III aminopeptide <ref type="bibr" target="#b29">[30]</ref>.</s><s>Furthermore, we demonstrated that human apo A-I gene transfer decreased cardiac fibrosis in an experimental rat model of diabetic cardiomyopathy <ref type="bibr" target="#b26">[27]</ref>.</s><s>With respect to the aorta, it has been shown that infusions of apo A-I mimetic peptide reduce fibrosis in the aortic root in a mouse model of aortic valve stenosis <ref type="bibr" target="#b30">[31]</ref>.</s><s>Recently, we showed that HDL supplementation to human aortic endothelial cells (HAEC) decreased transforming growth factor (TGF)-ß1-induced EndMT <ref type="bibr" target="#b13">[14]</ref>.</s></p><p><s>Given the endothelial-protective, anti-fibrotic, and immunomodulatory effects of HDL/apo A-I on the one hand, and the occurrence of vascular inflammation and fibrosis, and innate immune activation under obese conditions on the other hand, we aimed to investigate whether human apo A-I gene transfer can decrease aortic inflammation and fibrosis in leptin-deficient ob/ob mice, which are overweight <ref type="bibr" target="#b31">[32]</ref>, insulin-resistant <ref type="bibr" target="#b32">[33]</ref>, and develop vascular inflammation and fibrosis <ref type="bibr" target="#b33">[34,</ref><ref type="bibr" target="#b34">35]</ref>.</s><s>We next aimed to understand whether apo A-I/HDL might also affect vascular inflammation and fibrosis via systemic immunomodulation.</s><s>In this respect, in vitro studies were conducted to get insights in whether (i) HDL modulate the binding capacity of MNC to TNF-αactivated HAEC; and whether (ii) modulation of splenic activity following apo A-I transfer influences collagen production upon co-culture of those splenocytes with fibroblasts.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Animals and study design</head><p><s>Male B6.V-Lepod/JRj mice (ob/ob; Janvier Labs, Le Genest-Saint-Isle, France) were intravenously injected via the tail vein with saline or with 5 x 10 10 total particles of the E1E3E4-deleted adenoviral vector Ad.A-I expressing human apo A-I <ref type="bibr" target="#b35">[36]</ref> or of Ad.Null containing no expression cassette <ref type="bibr" target="#b35">[36]</ref>, at the age of 8 weeks.</s><s>As control reference, age-matched male C57BL/6 mice were injected with saline.</s><s>Mice were sacrificed 7 weeks later, the aorta was excised and snap-frozen in liquid nitrogen for molecular biology and the spleen was isolated for splenocyte preparation and subsequent flow cytometry or co-culture with murine fibroblasts.</s><s>Blood was withdrawn from the retro-orbital plexus at day 7, 21, 35, and 49 after gene transfer for determination of human apo A-I concentrations.</s><s>At day 45 after gene transfer or saline injection, an intraperitoneal glucose tolerance test was performed.</s><s>The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and was approved by the Institutional Animal Care and Research Advisory Committee of the Catholic University of Leuven (Approval number: P154/2013).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Human apo A-I ELISA</head><p><s>Human apo A-I levels were determined by sandwich ELISA as described previously <ref type="bibr" target="#b36">[37]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Plasma lipid analysis</head><p><s>Mouse lipoproteins were separated by density gradient ultracentrifugation as described by Jacobs et al. <ref type="bibr" target="#b37">[38]</ref>.</s><s>Fractions were stored at −20 °C until analysis.</s><s>Cholesterol in lipoprotein fractions was determined with commercially available enzymes (Roche Diagnostics, Basel, Switzerland).</s><s>Precipath L (Roche Diagnostics) was used as a standard.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Glucose tolerance test</head><p><s>Glucose tolerance test was performed by intraperitoneal injection of glucose (2 g/kg) after 6 h (h) of fasting as described by Hofmann et al. <ref type="bibr" target="#b38">[39]</ref>.</s><s>Tail blood glucose levels were measured with an Accu-Chek® Active Glucometer (Roche Applied Science, Penzberg, Germany) before (0 min) and at 15, 30, 60 and 120 min after injection.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Splenocyte isolation</head><p><s>Splenocytes were isolated from the different experimental groups as described previously <ref type="bibr" target="#b39">[40]</ref>.</s></p><p><s>(Splenocyte) mononuclear cell, CD4-, and CD8-T cell proliferation Splenocytes were labeled with 10 μM of succinimidyl ester of carboxyfluorescein diacetate (CFSE Cell Tract™; Invitrogen, Carlbard, CA, USA) to be able to measure cell proliferation, indicative for MNC activation, as described previously <ref type="bibr" target="#b40">[41]</ref>.</s><s>Therefore, splenocytes were cultured in RPMI1640 medium (Invitrogen, Heidelberg, Germany), supplemented with 10 % FBS and 1 % penicillin/streptomycin for 72 h.</s><s>Then, cells were stained with monoclonal anti-CD4 or anti-CD8 antibodies (BD Biosciences, Franklin Lakes, NJ, USA), followed by flow cytometry on a MACSQuant Analyzer (Miltenyi Biotec, Bergisch Gladbach, Germany) and analysis with FlowJo 8.7.</s><s>software (Tree Star) for the calculation of the division index, i.e. the average number of cell divisions that the responding cells undergo (i.e., ignores peak 0).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>TGF-ß1 expressing mononuclear cells</head><p><s>For the analysis of MNC expressing TGF-ß1, splenocytes were intracellulary stained with anti-TGF-ß1 (clone TW7-16B4 recognizing latency associated peptide (LAP), latent TGF-ß, and pro-TGF-ß; Biolegend, San Diego, CA, USA) after fixation.</s><s>Splenocyte samples were acquired on a MACSQuant Analyzer (Miltenyi Biotec, Bergisch Gladbach, Germany).</s><s>Analysis of flow cytometry data was performed using FlowJo software version 8.8.6.</s><s>(Tree Star Inc.).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell culture</head><p><s>Murine C4 fibroblasts, a murine fibroblast cell line derived from embryonic BALB/c mice by SV40 infection in vitro <ref type="bibr" target="#b41">[42]</ref>, were cultured in Basal Iscove medium supplemented with 10 % FBS and 1 % Penicillin/Streptomycin. Twentyfour h after plating at a cell density of 10,000 cells/96-well, cells were stimulated with/out 10 ng/ml TGF-ß1 (R&amp;D Systems, Minneapolis, USA) under serum starvation conditions, i.e.</s><s>Basal Iscove medium with 0.01 % FBS and 1 % Pencillin/Streptomycin, in the presence or absence of 50 μg/ml of HDL (MP Biomedicals, Solon, Ohio, USA) for 24 h.</s><s>Next, cells were fixed in methanol overnight at −20 °C for subsequent collagen deposition staining.</s></p><p><s>Human aortic endothelial cells (HAEC; Lonza, Basel, Switzerland) were cultured in Endothelial Basal Medium (Lonza) supplemented with the EGM-2 BulletKit (Lonza) on pre-coated (coating solution containing 0.02 % gelatin from bovine skin type B and 125 ng/ml fibronectin from bovine plasma; both Merck Chemicals, Darmstadt; Germany) cell culture flasks.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Co-culture of fibroblasts with splenocytes</head><p><s>Murine C4 fibroblasts were plated at a cell density of 10,000 cells/96-well in Basal Iscove medium supplemented with 10 % FBS and 1 % Penicillin/Streptomycin. Twenty-four h after plating, medium was removed and splenocytes isolated from control, ob/ob, ob/ob Ad.Null, and ob/ob Ad.A-I mice were added to the fibroblasts at a ratio of 10 splenic cells to 1 fibroblast in RPMI1640 medium (Invitrogen, Heidelberg, Germany) 10 % FBS, 1 % Penicillin/Streptomycin.</s><s>After 24 h, splenocytes were removed and the murine fibroblasts were fixed in methanol overnight at −20 °C for subsequent collagen deposition staining.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Quantification of collagen deposition</head><p><s>Collagen deposition was determined as described previously <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b42">43]</ref>.</s><s>In brief, after overnight fixation in methanol at −20 °C, cells were washed once with PBS and incubated in 0.1 % Direct Red 80 (Sirius red; Merck Chemicals, Darmstadt; Germany) staining solution at RT for 60 min.</s><s>After second washing with PBS, the Sirius red staining of the murine fibroblasts was eluted in 0.1 N sodium hydroxide at RT for 60 min on a rocking platform.</s><s>The optical density, representative for the accumulation of collagen, was measured at 540 nm.</s><s>For normalization to cell amount, murine fibroblasts were stained with crystal violet (Merck Chemicals, Darmstadt, Germany) and the absorbance was measured at 495 nm.</s><s>Data are represented as the ratio of the absorbance at 540 nm (Sirius Red) towards the absorbance at 495 nm (crystal violet).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Human peripheral blood mononuclear cell isolation</head><p><s>Blood was withdrawn from healthy donors (aged 40 to 65) with approval (EA4/115/11) from the Ethical Commission (Charité, CBF, Berlin).</s><s>Human peripheral blood mononuclear cells (MNC) were isolated from the blood samples by density-gradient centrifugation (Biocoll; Merck Millipore, Darmstadt, Germany).</s><s>Cells were stored in liquid nitrogen until use.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Adhesion assay</head><p><s>HAEC were plated in gelatin/fibronectin-coated black solid bottom 96-well plates, cultured for 24 h and treated with 10 ng/ml TNF-α (BD Pharmingen, Franklin Lakes, NJ, USA) in Endothelial Basal Medium for 4 h prior to addition of MNC.</s><s>DiO-labeled human MNC (DiO, Molecular Probes, Life Technologies) were cultured with/out 50 μg/ml of HDL for 24 h in 24-well plates and next added to TNF-α-stimulated HAEC at a ratio of 1:10 for 30 min.</s><s>Subsequently, MNC were removed by aspiration and HAEC were washed once with PBS.</s><s>PBS was added to each well and DiO-fluorescence was detected with a Mithras LB 940 multitechnology microplate reader (Berthold technologies) at wavelengths of 485 nm for excitation and 535 nm for emission and corresponding software (MikroWin 2000, Mikrotek Laborsysteme GmbH).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Gene expression analysis</head><p><s>RNA from the aorta was isolated using the RNeasy Mini Kit according to the manufacturer's protocol (Qiagen GmbH, Hilden, Germany), followed by cDNA synthesis.</s><s>To assess the mRNA expression of the target genes TNFα, VCAM-1, CD4, CD8, NOD2, NLRP3, collagen I and III, real-time PCR (Eppendorf Mastercycler epgradient realplex, Hamburg, Germany) was performed using gene expression assays for TNF-α Mm00443258_m1, VCAM-1 Mm01320970_m1, CD4 Mm00442754_m1, and CD8a Mm01182107_g1, nucleotide-binding oligomerization domain containing (NOD) 2 Mm00467543_m1, nucleotidebinding domain, leucine-rich-containing family, pyrin domain-containing (NLRP) 3 Mm00840904_m1, Col1a1 Hs00164004_m1, and Col3a1 Hs00943809_m1 from Applied Biosystems, respectively.</s><s>mRNA expression was normalized to the housekeeping gene CDKN1b (gene expression assay Hs00153277_m1) and relatively expressed with the control group set as 1.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Data are presented as mean ± SEM.</s><s>Statistical differences between groups were assessed with Ordinary One-way ANOVA.</s><s>Differences were considered to be significant when the P-value was lower than 0.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Metabolic modulation after human apo A-I transfer in ob/ ob mice</head><p><s>Human apo A-I gene transfer resulted in persistent expression of human apo A-I in ob/ob mice (Fig. <ref type="figure" target="#fig_0">1</ref>) leading to a 79 % (p &lt; 0.001) and 68 % (p &lt; 0.001) increase in HDL cholesterol levels at the day of sacrifice compared to ob/ob and ob/ob Ad.Null mice, respectively (Table <ref type="table" target="#tab_0">1</ref>).</s><s>At this age, ob/ob mice were still normoglycemic (Additional file 1: Figure <ref type="figure" target="#fig_0">S1A</ref>), but already glucose intolerant as evidenced by an intraperitoneal glucose tolerance test (Additional file 1: Figure <ref type="figure" target="#fig_0">S1B</ref>).</s><s>Ad.A-I transfer did not improve glucose intolerance (Additional file 1: Figure <ref type="figure" target="#fig_0">S1B</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Human apo A-I transfer exerts anti-inflammatory and immunomodulatory effects in ob/ob mice</head><p><s>Given the occurrence of inflammation in the vasculature under obesity on the one hand <ref type="bibr" target="#b0">[1]</ref> and the antiinflammatory properties of HDL/apo A-I on the other hand <ref type="bibr" target="#b26">[27,</ref><ref type="bibr" target="#b43">44]</ref>, we first evaluated whether apo A-I gene transfer could reduce aortic inflammation in obese mice.</s></p><p><s>Apo A-I gene transfer decreased aortic inflammation present in ob/ob mice as indicated by a 34 % (p &lt; 0.05) and 34 % (p &lt; 0.01) decrease in aortic TNF-α and VCAM-1 mRNA expression versus ob/ob mice, respectively (Fig. <ref type="figure">2a-b</ref>), and a 65 % (p = 0.066) and 62 % (p = 0.076) decline in CD4 and CD8 mRNA expression versus ob/ob mice, respectively (CD4 mRNA C57BL/6: 1 ± 0.28, ob/ob: 1.9 ± 0.44, ob/ob Ad.Null: 2.2 ± 0.69, ob/ob Ad.A-I: 0.66 ± 0.14; CD8 mRNA C57BL/6: 1.0 ± 0.32, ob/ob: 2.9 ± 0.94, ob/ob Ad.Null: 3.3 ± 1.0, ob/ob Ad.A-I: 1.1 ± 0.19; with p &lt; 0.05 for ob/ob Ad.A-I versus ob/ob Ad.Null).</s><s>Further evaluation of the pattern recognition receptor NOD2, which can be induced by TNF-α <ref type="bibr" target="#b8">[9]</ref>, and of the pattern recognition receptor NLRP3, demonstrated a 47 % (p &lt; 0.0005) and 52 % (p &lt; 0.05) decline, respectively, in their mRNA expression in ob/ob Ad.A-I versus ob/ob mice (Fig. <ref type="figure">2c-d</ref>).</s><s>To evaluate whether these changes in vascular inflammation and innate immunity following apo A-I gene transfer in ob/ob mice were accompanied with systemic immunomodulation, the impact of Ad.A-I on the activation/proliferation state of MNC, CD4+, and CD8+ T cells and on splenic TGF-ß1-expressing MNC was determined.</s><s>Ob/ob mice exhibited activated splenic MNC, CD4+, and CD8+ T cells as shown by a 13 % (p &lt; 0.05), 18 % (p &lt; 0.005), and 18 % (p &lt; 0.005) higher proliferation capacity compared to respective splenic cells from control C57BL/6 mice (Fig. <ref type="figure">3a-c</ref>).</s><s>In contrast, apo A-I gene transfer decreased the activation/proliferation of splenic total MNC, CD4+, and CD8+ cells in ob/ob mice by 12 % (p &lt; 0.05), 6.9 % (p &lt; 0.05), and 15 % (p &lt; 0.001), respectively (Fig. <ref type="figure">3a-c</ref>), and reduced the percentage of MNC   expressing TGF-ß1 by 28 % (p &lt; 0.05) in ob/ob mice (Fig. <ref type="figure">4</ref>).</s><s>To further evaluate whether the immunomodulatory effects of HDL also include their ability to reduce the capacity of MNC to bind to endothelial cells, MNC pre-cultured with/out HDL were added to TNF-αstimulated HAEC and their adhesion was measured.</s></p><p><s>Pre-culture of MNC with HDL resulted in a 63 % (p &lt; 0.0001) lower adhesion to TNF-α-stimulated HAEC compared to untreated MNC (Fig. <ref type="figure">5</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Anti-fibrotic effects after human apo A-I transfer in ob/ob mice</head><p><s>The relevance of vascular fibrosis in obesity <ref type="bibr" target="#b2">[3]</ref> and the anti-fibrotic effects of HDL/apo A-I <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref> further motivated us to evaluate the impact of Ad.A-I on the aortic mRNA expression of fibrosis markers.</s><s>Ob/ob mice exhibited a 459 % (p &lt; 0.0001) and 243 % (p &lt; 0.0005) higher collagen I and III mRNA expression, respectively, compared to control C57BL/6 mice, whereas AdA-I transfer in ob/ob mice resulted in a 62 % (p &lt; 0.0005) decrease of collagen I mRNA and a 66 % (p &lt; 0.0005) decrease of collagen III mRNA (Fig. <ref type="figure">6</ref>).</s><s>Given the link between immune cells and fibrosis on the one hand <ref type="bibr" target="#b12">[13]</ref> and the importance of fibrosis in vascular remodeling on the other hand <ref type="bibr" target="#b44">[45]</ref>, we next evaluated the impact of the immunomodulatory effects of apo A-I gene transfer on collagen production in fibroblasts upon co-culture of splenocytes isolated from the different experimental groups on fibroblasts.</s><s>Coculture of splenocytes from ob/ob and ob/ob Ad.Null mice with murine fibroblasts augmented collagen deposition by 54 % (p &lt; 0.0001) and 50 % (p &lt; 0.0005), respectively, compared to monoculture of fibroblasts.</s><s>In contrast, splenocytes from ob/ob Ad.A-I mice and from control mice did not induce collagen content in fibroblasts upon co-culture (Fig. <ref type="figure">7a</ref>).</s><s>To evaluate whether HDL themselves reduce collagen deposition in murine fibroblasts, HDL were supplemented to fibroblasts stimulated with TGF-ß1.</s><s>TGF-ß1 increased the collagen deposition in murine fibroblasts by 43 % (p &lt; 0.01).</s><s>In contrast, HDL reduced the TGF-ß1-induced collagen deposition to levels not different from controls (Fig. <ref type="figure">7b</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The salient findings of the present study are that apo A-I gene transfer exerts immunomodulatory effects and Leptin-deficient ob/ob mice are overweight <ref type="bibr" target="#b31">[32]</ref>, insulinresistant <ref type="bibr" target="#b32">[33]</ref>, and develop type 2 diabetes mellitus over time due to deficiency of the appetite regulating hormone leptin, which has immunomodulatory properties <ref type="bibr" target="#b45">[46]</ref>.</s><s>In agreement with Xu et al. <ref type="bibr" target="#b46">[47]</ref>, ob/ob mice were still normoglycemic at an age of 15 weeks.</s><s>However, a glucose tolerance test 4 days before sacrifice indicated a disturbance in glucose metabolism, which could not be overcome via apo A-I gene transfer.</s><s>Furthermore, ob/ob mice exhibited hypercholesterolemia and dyslipoproteinemia (non-HDL to HDL-cholesterol ratio 1:1) in the absence of raised triglyceride levels.</s><s>In agreement with apo A-I gene transfer studies in certain atherosclerosis models <ref type="bibr" target="#b47">[48,</ref><ref type="bibr" target="#b48">49]</ref>, Ad.A-I transfer induced increased triglyceride levels in ob/ ob mice.</s><s>Under these metabolic conditions, we demonstrate that apo A-I gene transfer led to a downregulation of aortic TNF-α and VCAM-1 mRNA in ob/ob mice.</s><s>We and others have shown that apo A-I reduces TNF-α expression <ref type="bibr" target="#b26">[27,</ref><ref type="bibr" target="#b49">50]</ref>, which is an important inducer of VCAM-1 expression <ref type="bibr" target="#b43">[44]</ref>.</s><s>Downregulation of aortic VCAM-1 mRNA expression in ob/ob mice after apo A-I gene transfer is -on its turn -in agreement with the wellestablished potential of apo A-I and HDL to decrease the expression of cytokine-induced adhesion molecules <ref type="bibr" target="#b43">[44]</ref>.</s><s>This downregulated aortic VCAM-1 together with the decreased CD4 and CD8a mRNA expression in ob/ob Ad.A-I compared to ob/ob mice suggests a lower presence of CD4 and CD8 cells in the aorta of ob/ob Ad.A-I compared to ob/ob mice.</s><s>Our in vitro findings further illustrate that HDL lower the capacity of MNC to adhere to TNF-α-activated aortic endothelial cells.</s><s>This implies that HDL can decrease the adhesion of immune cells to the aortic endothelium via their endothelial-protective (lowering VCAM-1 expression) as well as immunomodulating capacity (decreasing the binding capacity of MNC to activated endothelial cells).</s><s>This impaired immune cell adhesion and consequently lower presence of immune cells in the vascular wall, were expected to reduce fibrosis in the aorta of ob/ob Ad.A-I versus ob/ob mice, due to the lower burden of inflammation <ref type="bibr" target="#b12">[13]</ref>.</s><s>Indeed, we found that the aortic collagen I and III mRNA expression was lower in ob/ob Ad.A-I versus ob/ob mice, which can also be explained via a direct anti-fibrotic effect of HDL.</s><s>This mechanism is corroborated by our in vitro finding indicating that HDL reduce the TGF-ß1-induced collagen deposition in murine fibroblasts and is further supported by our recent observation that HDL are capable of decreasing TGF-ß1-induced EndMT in aortic endothelial cells in vitro <ref type="bibr" target="#b13">[14]</ref>.</s><s>In this context, another explanation for the reduction in aortic collagen expression following apo A-I gene transfer could be the decrease in TGF-ß1-expressing splenic MNC in ob/ob Ad.A-I versus ob/ob mice, and subsequent lower induction of EndMT in ob/ ob mice.</s></p><p><s>Evidence for the immunomodulatory capacity of apo A-I gene transfer in ob/ob mice follows at first from the reduction in aortic mRNA expression of the NLR proteins NOD2 and NLRP3 in ob/ob Ad.A-I versus ob/ob mice.</s><s>NOD2 leads to NF-kB activation and subsequent expression of TNF-α and NLRP3 <ref type="bibr" target="#b50">[51]</ref>.</s><s>Its downregulation following apo A-I gene transfer can therefore partly explain the reduction in aortic TNF-α expression.</s><s>Based on the involvement of NOD2 in fibrosis <ref type="bibr" target="#b10">[11]</ref>, its endothelial expression <ref type="bibr" target="#b8">[9]</ref> and the capacity of HDL to reduce EndMT <ref type="bibr" target="#b13">[14]</ref>, we further speculate that an increase of HDL via apo A-I gene transfer can partly account for the reduction in aortic collagen I and III expression via decreasing EndMT, involving NOD2.</s><s>The aortic downregulation of NLRP3, which has emerged as an important regulator of inflammation in metabolic disorders and atherosclerosis <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b6">7]</ref> and is recognized for its capacity to induce collagen production in fibroblasts <ref type="bibr" target="#b11">[12]</ref>, supports the link between the decrease in vascular inflammation and fibrosis after apo A-I gene transfer.</s></p><p><s>Besides its impact on the aortic expression of NLRs, Ad.A-I transfer led to systemic immunomodulatory effects as indicated by a decline in the increased proliferation/activity of splenic MNC, CD4+ and CD8+ T cells in ob/ob mice.</s><s>This finding is supported by Wilhelm et al. <ref type="bibr" target="#b23">[24]</ref> who showed that apo A-I prevents T cell activation and proliferation in peripheral lymph nodes in mice fed an atherogenic diet.</s><s>In addition, we found that apo A-I gene transfer reduced the percentage of splenic MNC expressing the pro-fibrotic factor TGF-ß1.</s><s>Concomitantly, co-culture of splenocytes from ob/ob Ad.A-I mice did not induce collagen production in murine fibroblasts, in contrast to splenocytes from ob/ob and ob/ob Ad.Null mice, suggesting that apo A-I-raising transfer reduces the pro-fibrotic potential of splenocytes under obese conditions and their subsequent contribution to vascular fibrosis.</s><s>This hypothesis, supporting the existence of a vasculosplenic axis, i.e. the migration of immune cells from the spleen to the vasculature and subsequent involvement in vascular fibrosis builds further on the existence of the cardiosplenic axis, which importance has mainly been recognized in ischemic heart disease <ref type="bibr" target="#b51">[52]</ref>.</s><s>This postulation should be taken with caution as long as the existence of a vasculosplenic axis and its relevance in vascular fibrosis is confirmed in additional experiments in ob/ob mice.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Limitations of the study</head><p><s>Whereas the present study reveals systemic immunomodulatory and local (aorta) immunomodulatory/antifibrotic effects following apo A-I transfer in ob/ob mice, further characterization of the systemic immunomodulatory effects mice including cytokine profiles of circulating immune cells as well as the analysis of fibrosis in other vascular beds and/or adipose tissue is required to deepen our insights into the link between inflammation and fibrosis in ob/ob mice and the impact of apo A-I transfer on both parameters.</s><s>Furthermore, experiments in high-fat diet-induced obesity, associated with hyperleptineamia (dysfunctional leptin), would be of value to confirm our findings.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>We demonstrated that apo A-I-raising transfer exerts immunomodulatory effects in ob/ob mice, including the reduction in the aortic expression of the pattern recognition receptors NOD2 and NLRP3, and the decrease in activity of splenic MNC, which are associated with a decrease in vascular inflammation and fibrosis.</s><s>These findings further corroborate the immunomodulatory and vascular-protective potential of apo A-I/HDL.</s><s>Furthermore, they point out that under obese conditions, modulation of the chronic low-grade activation of the innate immune system (NOD2, NLRP3) per se, may counteract vascular inflammation and fibrosis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Additional file</head><p><s>Additional file 1: Figure <ref type="figure" target="#fig_0">S1</ref>.</s><s>Impact of apo A-I transfer on blood glucose levels and glucose responsiveness in ob/ob mice.</s><s>(TIFF 1521 kb)</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1</head><label>1</label><figDesc><div><p><s>Fig. 1 Human apo A-I levels after apo A-I gene transfer in ob/ob mice.</s><s>Data represent mean ± SEM of n = 4 mice</s></p></div></figDesc><graphic coords="4,314.02,94.85,215.21,205.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 Fig. 3 (</head><label>23</label><figDesc><div><p><s>Fig. 2 Impact of apo A-I gene transfer on aortic TNF-α, VCAM-1, NOD2, and NLRP3 mRNA expression in ob/ob mice.</s><s>Bar graphs represent the mean ± SEM of aortic a. TNF-α, b.</s><s>VCAM-1, c. NOD2 and d.</s><s>NLRP3 mRNA expression with n = 6-7 for C57BL/6, n = 11 for ob/ob, n = 8-10 for ob/ob Null and n = 10 for ob/ob A-I; *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.005 and ****p &lt; 0.0001</s></p></div></figDesc><graphic coords="5,63.84,266.63,467.66,426.39" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 4 Fig. 5 Fig. 3</head><label>453</label><figDesc><div><p><s>Fig. 4 Impact of apo A-I gene transfer on splenic TGF-ß + mononuclear cells.</s><s>Bar graphs represent the mean ± SEM of the % of splenic TGF-ß + mononuclear cells (MNC) with n = 5-6/group; *p &lt; 0.05</s></p></div></figDesc><graphic coords="7,65.99,489.26,215.21,203.81" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 6 Fig. 7</head><label>67</label><figDesc><div><p><s>Fig. 6 Impact of apo A-I gene transfer on aortic collagen I and III mRNA expression in ob/ob mice.</s><s>Bar graphs represent the mean ± SEM of aortic a. collagen I and b. collagen III mRNA expression with n = 7 for C57BL/6, n = 9-10 for ob/ob groups; *p &lt; 0.05, **p &lt; 0.0005, and ***p &lt; 0.0001</s></p></div></figDesc><graphic coords="8,127.28,94.85,340.76,161.41" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Plasma cholesterol, non-HDL cholesterol, HDL cholesterol and plasma triglycerides at 6 weeks after saline injection or gene transfer</s></p></div></figDesc><table><row><cell></cell><cell>Cholesterol</cell><cell>Non-HDL Cholesterol</cell><cell>HDL Cholesterol</cell><cell>Triglycerides</cell></row><row><cell>C57BL/6</cell><cell>66.7 ± 7.3</cell><cell>15.4 ± 2.0</cell><cell>51.3 ± 5.9</cell><cell>45.6 ± 4.4</cell></row><row><cell>Ob/ob</cell><cell>144 ± 7  § § §</cell><cell>71.8 ± 3.9  § § §</cell><cell>72.7 ± 4.3  §</cell><cell>51.6 ± 3.9</cell></row><row><cell>Ob/ob Ad.Null</cell><cell>153 ± 2  § § §</cell><cell>76.0 ± 2.5  § § §</cell><cell>77.5 ± 2.</cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We would like to acknowledge the assistance of the BCRT Flow Cytometry Lab.</s><s>We thank Annika Koschel, Gwendolin Matz, and Marzena Sosnowski (in alphabetical order) for excellent technical support.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Abbreviations</head><p><s>Apo, apolipoprotein; EndMT, endothelial-to-mesenchymal-transition; HDL, high-density lipoprotein; MNC, mononuclear cell; NLRP3, nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing 3; NOD2, nucleotide-binding oligomerization domain containing 2; TGF, transforming growth factor</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p><s>This study was supported by the European Foundation for the study of diabetes (EFSD) to SVL and by the DZHK to CT and SVL.</s><s>This work was also endorsed by Onderzoekstoelagen grant OT/13/090 of the KU Leuven and by grant G0A3114N of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen to BDG.</s><s>Ilayaraja Muthuramu is a postdoctoral fellow of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Availability of data and materials</head><p><s>The datasets of the current study are available from the corresponding author upon reasonable request.</s></p><p><s>Authors' contributions FS participated in the design of the study, performed statistical analysis and drafted the manuscript.</s><s>BDG performed lipoprotein analysis, participated in the experimental design, and performed statistical analysis.</s><s>IM performed the in vivo experiments including oral glucose tolerance test.</s><s>RA performed the in vivo experiment.</s><s>KM carried out flow cytometry and performed statistical analysis.</s><s>BP gave final approval of the version to be published.</s><s>CT revised the manuscript critically for important intellectual content and gave final approval of the version to be published.</s><s>SVL performed study design and conception, data interpretation, and statistical analysis and helped to draft the manuscript.</s><s>All authors read and approved the final manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Competing interests</head><p><s>The authors declare that they have no competing interests.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Consent for publication</head><p><s>Not applicable.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethics approval and consent to participate</head><p><s>The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and was approved by the Institutional Animal Care and Research Advisory Committee of the Catholic University of Leuven (Approval number: P154/2013).</s><s>Blood was withdrawn from healthy donors (aged 40 to 65) with approval (EA4/115/11) from the Ethical Commission (Charité, CBF, Berlin).</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Inflammatory links between obesity and metabolic disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Lumeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Saltiel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="2111" to="2117" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Caballero</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obes Res</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1278" to="1289" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Circulating endothelial progenitor cells, microvascular density and fibrosis in obesity before and after bariatric surgery</title>
		<author>
			<persName><forename type="first">C</forename><surname>De Ciuceis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rossini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Porteri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">La</forename><surname>Boria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Corbellini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mittempergher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood Press</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="165" to="172" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Body mass index and mortality in nonsmoking older adults: the Cardiovascular Health Study</title>
		<author>
			<persName><forename type="first">P</forename><surname>Diehr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Bild</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Duxbury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Siscovick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rossi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Public Health</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="623" to="629" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Obesity and the risk of heart failure</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kenchaiah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Benjamin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Larson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">347</biblScope>
			<biblScope unit="page" from="305" to="313" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals</title>
		<author>
			<persName><forename type="first">P</forename><surname>Duewell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Rayner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Sirois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vladimer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Bauernfeind</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">464</biblScope>
			<biblScope unit="page" from="1357" to="1361" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance</title>
		<author>
			<persName><forename type="first">B</forename><surname>Vandanmagsar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Youm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ravussin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Galgani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stadler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Mynatt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="179" to="188" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Innate immune receptor NOD2 promotes vascular inflammation and formation of lipid-rich necrotic cores in hypercholesterolemic mice</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Johansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Edfeldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Lundberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Levin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Boren</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="3081" to="3092" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Induction and localization of NOD2 protein in human endothelial cells</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Seo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">Y</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kweon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Chun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Immunol</title>
		<imprint>
			<biblScope unit="volume">237</biblScope>
			<biblScope unit="page" from="37" to="44" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Endothelial NLRP3 inflammasome activation and enhanced neointima formation in mice by adipokine visfatin</title>
		<author>
			<persName><forename type="first">M</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Boini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Abais</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">184</biblScope>
			<biblScope unit="page" from="1617" to="1628" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Mechanisms that mediate the development of fibrosis in patients with Crohn&apos;s disease</title>
		<author>
			<persName><forename type="first">C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Kuemmerle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Inflamm Bowel Dis</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="1250" to="1258" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Activation in M1 but not M2 Macrophages Contributes to Cardiac Remodeling after Myocardial Infarction in Rats: a Critical Role of the Calcium Sensing Receptor/NRLP3 Inflammasome</title>
		<author>
			<persName><forename type="first">W</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Chi</forename><forename type="middle">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Physiol Biochem</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="2483" to="2500" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Crosstalk between fibroblasts and inflammatory cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Van Linthout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miteva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tschope</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Res</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="258" to="269" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">High-Density Lipoproteins Reduce Endothelial-to-Mesenchymal Transition</title>
		<author>
			<persName><forename type="first">F</forename><surname>Spillmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miteva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Pieske</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tschope</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Van Linthout</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler Thromb Vasc Biol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1774" to="1777" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Endothelial-to-mesenchymal transition contributes to cardiac fibrosis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Zeisberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Tarnavski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zeisberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Dorfman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mcmullen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gustafsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="952" to="961" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Endothelial NADPH oxidase-2 promotes interstitial cardiac fibrosis and diastolic dysfunction through proinflammatory effects and endothelial-mesenchymal transition</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Murdoch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chaubey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ivetic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Walker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="2734" to="2741" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">TGF-beta signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Cooley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nevado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mellad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">St</forename><surname>Hilaire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Negro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Transl Med</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="227" to="234" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Plasma high-density lipoprotein cholesterol: association with measurements of body mass. The Lipid Research Clinics Program Prevalence Study</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Glueck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Morrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Beaglehole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">D</forename><surname>Williams</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="62" to="69" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Innate and adaptive immunity in the pathogenesis of atherosclerosis</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Hansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Libby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Schonbeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">Q</forename><surname>Yan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="281" to="291" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus</title>
		<author>
			<persName><forename type="first">E</forename><surname>Svenungsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gunnarsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">Z</forename><surname>Fei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">E</forename><surname>Lundberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Klareskog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Frostegard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="2533" to="2540" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Van Halm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Nielen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Nurmohamed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Van Schaardenburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Reesink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Voskuyl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="184" to="188" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Down-regulation of endothelial TLR4 signalling after apo A-I gene transfer contributes to improved survival in an experimental model of lipopolysaccharide-induced inflammation</title>
		<author>
			<persName><forename type="first">S</forename><surname>Van Linthout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Spillmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Graiani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miteva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Van Craeyveld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Med (Berl)</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="151" to="160" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">HDL and immunomodulation: an emerging role of HDL against atherosclerosis</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Q</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Zhao</forename><surname>Sp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="285" to="290" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Wilhelm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zabalawi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Grayson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Weant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Major</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Owen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler Thromb Vasc Biol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="843" to="849" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Yuhanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Hahner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Osborne-Lawrence</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="853" to="857" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor</title>
		<author>
			<persName><forename type="first">S</forename><surname>Van Linthout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Spillmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lorenz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Meloni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Egorova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="682" to="687" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy</title>
		<author>
			<persName><forename type="first">S</forename><surname>Van Linthout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Spillmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Riad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Trimpert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lievens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Meloni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="1563" to="1573" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Overexpression of apolipoprotein A1 in the lung abrogates fibrosis in experimental silicosis</title>
		<author>
			<persName><forename type="first">E</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Koh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Uh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e55827</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biomed Sci</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">58</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance</title>
		<author>
			<persName><forename type="first">D</forename><surname>Quilliot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alla</forename><forename type="middle">F</forename><surname>Bohme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bruntz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Hammadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dousset</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Obes (Lond)</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1321" to="1328" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Improvement of aortic valve stenosis by ApoA-I mimetic therapy is associated with decreased aortic root and valve remodelling in mice</title>
		<author>
			<persName><forename type="first">J</forename><surname>Trapeaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Busseuil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nobari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Shustik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mecteau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="1587" to="1599" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Effects of the obese gene product on body weight regulation in ob/ob mice</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Pelleymounter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Cullen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Winters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Boone</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">269</biblScope>
			<biblScope unit="page" from="540" to="543" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Modulation of insulin activities by leptin</title>
		<author>
			<persName><forename type="first">B</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Novick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rubinstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">274</biblScope>
			<biblScope unit="page" from="1185" to="1188" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Obesityrelated dysfunction of the aorta and prevention by melatonin treatment in ob/ob mice</title>
		<author>
			<persName><forename type="first">G</forename><surname>Favero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lonati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Giugno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Castrezzati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Rodella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rezzani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Histochem</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="783" to="788" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Increased aortic stiffness and attenuated lysyl oxidase activity in obesity</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Tai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">T</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler Thromb Vasc Biol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="839" to="846" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector</title>
		<author>
			<persName><forename type="first">S</forename><surname>Van Linthout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lusky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Collen</forename><forename type="middle">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Geest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene Ther</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="1520" to="1528" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Sustained expression of human apo A-I following adenoviral gene transfer in mice</title>
		<author>
			<persName><forename type="first">B</forename><surname>De Geest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Van Linthout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Collen</forename><forename type="middle">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene Ther</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="121" to="127" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Adenoviral low density lipoprotein receptor attenuates progression of atherosclerosis and decreases tissue cholesterol levels in a murine model of familial hypercholesterolemia</title>
		<author>
			<persName><forename type="first">F</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Van Craeyveld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Snoeys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Geest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Atherosclerosis</title>
		<imprint>
			<biblScope unit="volume">201</biblScope>
			<biblScope unit="page" from="289" to="297" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Defective lipid delivery modulates glucose tolerance and metabolic response to diet in apolipoprotein E-deficient mice</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Hofmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Perez-Tilve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Greer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Coburn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Grant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Basford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="5" to="12" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Miteva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Haag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Savvatis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Becher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Seifert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">e28513</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Van Linthout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Savvatis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miteva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ringe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Warstat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="2168" to="2178" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up-or down-regulate antigen presentation at nontoxic doses</title>
		<author>
			<persName><forename type="first">K</forename><surname>Schwarz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>De Giuli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schmidtke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kostka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Den Broek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">164</biblScope>
			<biblScope unit="page" from="6147" to="6157" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Savvatis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Van Linthout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miteva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Pappritz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Westermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Schefold</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e41047</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">The apolipoprotein A-I mimetic peptide ETC.-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins</title>
		<author>
			<persName><forename type="first">Di</forename><surname>Bartolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Nicholls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Heather</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Barter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Atherosclerosis</title>
		<imprint>
			<biblScope unit="volume">217</biblScope>
			<biblScope unit="page" from="395" to="400" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Transcription Factor Runx2 Promotes Aortic Fibrosis and Stiffness in Type 2 Diabetes Mellitus</title>
		<author>
			<persName><forename type="first">U</forename><surname>Raaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">N</forename><surname>Schellinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Chernogubova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Warnecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Penov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="513" to="524" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Leptin in the regulation of immunity, inflammation, and hematopoiesis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Fantuzzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Faggioni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Leukoc Biol</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="437" to="446" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Chronic inflammation in fat plays a crucial role in the development of obesityrelated insulin resistance</title>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T</forename><surname>Barnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Chou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="1821" to="1830" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies</title>
		<author>
			<persName><forename type="first">E</forename><surname>Van Craeyveld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Gordts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Nefyodova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Geest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Med (Berl)</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="555" to="567" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus</title>
		<author>
			<persName><forename type="first">K</forename><surname>Tsukamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Hiester</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Usher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Glick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Rader</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Lipid Res</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="1869" to="1876" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes</title>
		<author>
			<persName><forename type="first">N</forename><surname>Hyka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Dayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Modoux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Edwards 3rd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Roux-Lombard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="2381" to="2389" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Mechanism of NLRP3 inflammasome activation</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Sutterwala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Haasken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Cassel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">1319</biblScope>
			<biblScope unit="page" from="82" to="95" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Ismahil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hamid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Bansal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Kingery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Prabhu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="266" to="282" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
